Search

Displaying results 8051 - 8060 of 10000 in total
  1. Drug

    Whey

    go.drugbank.com/drugs/DB18685
    Experimental

    Whey allergenic extract is used in allergenic testing.

  2. Drug

    RCT-1213

    go.drugbank.com/drugs/DB32727
    Experimental

    RCT-1213 is an anti-TM4SF5 monoclonal antibody.

  3. Drug

    Imagabalin

    go.drugbank.com/drugs/DB12105
    Investigational

    Imagabalin has been investigated in Generalized Anxiety Disorder.

  4. Drug

    Vinylglycine

    go.drugbank.com/drugs/DB03214
    Experimental

    Vinylglycine is an irreversible inhibitor of aspartate aminotransferase.

  5. Drug

    Lanraplenib

    go.drugbank.com/drugs/DB14770
    Investigational

    Lanraplenib is under investigation in clinical trial NCT03285711 (Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)).

  6. Drug

    Afasevikumab

    go.drugbank.com/drugs/DB14798
    Investigational

    Afasevikumab is under investigation in clinical trial NCT01480310 (Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers).

  7. Drug

    BIO-11006

    go.drugbank.com/drugs/DB14886
    Investigational

    BIO-11006 is under investigation in clinical trial NCT03202394 (Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS).

  8. Drug

    AZD8529

    go.drugbank.com/drugs/DB16073
    Investigational

    AZD8529 is under investigation in clinical trial NCT00921804 (Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients).

  9. Drug

    Ciforadenant

    go.drugbank.com/drugs/DB16125
    Investigational

    Ciforadenant is under investigation in clinical trial NCT02253745 (Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)).

  10. Drug

    Cinpanemab

    go.drugbank.com/drugs/DB16127
    Investigational

    Cinpanemab is under investigation in clinical trial NCT03318523 (Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease).